Last reviewed · How we verify

Moderate to severe hidradenitis suppurativa

5 treatments

Approved treatments

Competitive intelligence

For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:

Frequently asked questions about Moderate to severe hidradenitis suppurativa

What drugs treat Moderate to severe hidradenitis suppurativa?

Tracked treatments include Induction- PF-06480605 450 mg SC Q4W, Chronic- PF-06480605 50 mg SC Q4W, Chronic- PF-06480605 150 mg SC Q4W, Chronic- PF-06480605 450 mg SC Q4W.

What is the treatment for Moderate to severe hidradenitis suppurativa?

Standard treatment for Moderate to severe hidradenitis suppurativa includes Induction- PF-06480605 450 mg SC Q4W, Chronic- PF-06480605 50 mg SC Q4W, Chronic- PF-06480605 150 mg SC Q4W, Chronic- PF-06480605 450 mg SC Q4W. See the treatment landscape page for first-line, second-line and salvage options.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing